<DOC>
	<DOCNO>NCT02718716</DOCNO>
	<brief_summary>The primary objective study check subcutaneous ( sc ) infusion UCB7665 safe tolerate subject primary immune thrombocytopenia .</brief_summary>
	<brief_title>Study Evaluate Safety , Tolerability Efficacy UCB7665 Subjects With Primary Immune Thrombocytopenia</brief_title>
	<detailed_description />
	<mesh_term>Thrombocytopenia</mesh_term>
	<mesh_term>Purpura , Thrombocytopenic , Idiopathic</mesh_term>
	<criteria>Subject diagnosis primary immune thrombocytopenia ( ITP ) minimum 3 month prior Screening Visit Subject platelet count &lt; 30x10^9/L Screening &lt; 35x10^9/L Baseline ( Visit 2 ) Subject current history peripheral blood smear consistent ITP Subject respond previous ITP therapy ( accord judgment investigator ) Subject immunoglobulin G ( IgG ) level ≤6g/L Screening Visit Subject partial thromboplastin time ( PTT ) ≥1.5x upper limit normal ( ULN ) International Normalized Ratio ( INR ) ≥1.5 Screening Visit Subject renal and/or liver impairment define : Serum creatinine level ≥1.4 mg/dL female ≥1.5 mg/dL male Screening Visit Subject plan elective surgical procedure come 6 month Subject evidence secondary cause primary immune thrombocytopenia Subject history clinically relevant ongoing chronic infection Subject family history primary immunodeficiency Subject clinically relevant active infection serious infection within 6 week prior first dose IMP Subject history know inflammatory bowel disease , diverticular disease , gastric esophageal ulceration Subject experience gastrointestinal bleed last 6 month prior Screening Visit and/or current gastritis esophagitis Subject medical history thrombosis Subject history coagulopathy disorder Subject receive live vaccination within 8 week prior Baseline Visit ; intend live vaccination course study within 7 week follow final dose IMP Subject prior treatment rituximab 6 month prior Baseline Subject complete washout period immune suppressant , biologics therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>ITP</keyword>
</DOC>